Task: Answer the MCQ question.
Question: Which drug exhibits a 25.559% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) CCOc1ccccc1C1C(C#N)=C(N)Oc2cc(C)n(Cc3ccccn3)c(=O)c21
b.) O=C(O)CCCn1ccc2cc(S(=O)(=O)N3CCCC3)ccc21
c.) COc1cc(/C=C/C(=O)OCC(=O)N(C)CC(=O)Nc2ccc(F)cc2)ccc1OC(F)F
d.) CNC(=O)[C@@]1(Cc2ccccc2)C=C[C@@H](C)N1C(C)=O
e.) Cc1ccsc1/C=N\NC(=O)CCc1c(C)n[nH]c1C
Answer: b. O=C(O)CCCn1ccc2cc(S(=O)(=O)N3CCCC3)ccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(O)CCCn1ccc2cc(S(=O)(=O)N3CCCC3)ccc21
O=C(O)CCCn1ccc2cc(S(=O)(=O)N3CCCC3)ccc21
4-(5-pyrrolidin-1-ylsulfonylindol-1-yl)butanoicacid